Cullinan Therapeutics, Inc. (CGEM) vs Janux Therapeutics, Inc. (JANX)
A side-by-side comparison of Cullinan Therapeutics, Inc. and Janux Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEM
Cullinan Therapeutics, Inc.
$16.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
JANX
Janux Therapeutics, Inc.
$16.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CGEM vs JANX
growth of $100 · dividends reinvested · last 5yCGEM -48.9% (-12.6%/yr)JANX -34.2% (-8.0%/yr)JANX compounded faster over this window
CGEM JANX
CGEM vs JANX: by the numbers
- •JANX is the larger company ($1.02B vs $999M market cap).
- •Both run net losses; CGEM's is the smaller (0.00% vs -321.81% net margin).
Metrics side by side
Valuation
| Metric | CGEM | JANX |
|---|---|---|
| P/S ratio | N/A | 32.12 |
| P/B ratio | 3.10 | 1.10 |
Profitability
| Metric | CGEM | JANX |
|---|---|---|
| Gross margin | 0.00% | 79.71% |
| Operating margin | 0.00% | -1576.67% |
| Net margin | 0.00% | -321.81% |
| ROE | -63.62% | -11.06% |
| ROIC | -68.64% | -15.15% |
Growth (annualized)
| Metric | CGEM | JANX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.89% |
| Total return CAGR (5Y) | -7.48% | -6.45% |
Frequently asked
- How have CGEM and JANX total returns compared?
- Over the past 5 years, CGEM delivered -7.48% and JANX delivered -6.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cullinan Therapeutics ROEJanux Therapeutics ROECullinan Therapeutics operating marginJanux Therapeutics operating marginCullinan Therapeutics revenue growthJanux Therapeutics revenue growthCullinan Therapeutics free cash flowJanux Therapeutics free cash flow
Cullinan Therapeutics & Janux Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.